Screener
Hemab Therapeutics Holdings, Inc. COAG Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Hemab Therapeutics Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncome.
The source filing: Hemab Therapeutics Holdings, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344533
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other income (expense), net | ||||
| Interest income | 2,858 | 335 | 4,077 | 808 |
| Other (expense) income, net | (832) | 3,517 | (1,114) | 4,108 |
| Total other income, net | 2,026 | 3,852 | 2,963 | 4,916 |
| Loss before income tax expense | (24,053) | (12,205) | (46,728) | (27,701) |
| Income tax (expense) benefit | (97) | (4) | (109) | 186 |
| Net loss | $(24,150) | $(12,209) | $(46,837) | $(27,515) |
| Net loss per share, basic and diluted | $(0.80) | $(12.91) | $(3.00) | $(29.09) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Hemab Therapeutics Holdings, Inc.'s other income (expense)?
- Hemab Therapeutics Holdings, Inc. (COAG) reported other income (expense) of $2.03M in Q2 2026.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Hemab Therapeutics Holdings, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude